Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study.
Tokuda PJK, Mitsuyoshi T, Ono Y, Kishi T, Negoro Y, Okumura S, Ikeda I, Sakamoto T, Kokubo Y, Ashida R, Imagumbai T, Yamashita M, Tanabe H, Takebe S, Tokiwa M, Suzuki E, Yamauchi C, Yoshimura M, Mizowaki T, Kokubo M; Kyoto Radiation Oncology Study Group. Tokuda PJK, et al. Among authors: mitsuyoshi t. Breast Cancer. 2024 Apr 12. doi: 10.1007/s12282-024-01577-3. Online ahead of print. Breast Cancer. 2024. PMID: 38607499
Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study).
Mitsuyoshi T, Ono Y, Ashida R, Yamashita M, Tanabe H, Takebe S, Tokiwa M, Suzuki E, Imagumbai T, Yoshimura M, Yamauchi C, Mizowaki T, Kokubo M. Mitsuyoshi T, et al. Jpn J Clin Oncol. 2023 Jan 28;53(2):174-178. doi: 10.1093/jjco/hyac174. Jpn J Clin Oncol. 2023. PMID: 36420578 Free PMC article. Clinical Trial.
Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer.
Kishi N, Matsuo Y, Shintani T, Ogura M, Mitsuyoshi T, Araki N, Fujii K, Okumura S, Nakamatsu K, Kishi T, Atsuta T, Sakamoto T, Ohtsu S, Katagiri T, Narabayashi M, Fujishiro S, Iizuka Y, Ozasa H, Hirai T, Mizowaki T; Kyoto Radiation Oncology Study Group (KROSG). Kishi N, et al. Among authors: mitsuyoshi t. J Radiat Res. 2023 Jan 20;64(1):142-153. doi: 10.1093/jrr/rrac057. J Radiat Res. 2023. PMID: 36149029 Free PMC article.
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.
Yamasaki-Morita M, Arai Y, Ishihara T, Onishi T, Shimo H, Nakanishi K, Nishiyama Y, Jo T, Hiramatsu H, Mitsuyoshi T, Mizumoto C, Kanda J, Nishikori M, Kitawaki T, Nogami K, Takaori-Kondo A, Nagao M, Adachi S. Yamasaki-Morita M, et al. Among authors: mitsuyoshi t. Blood Adv. 2022 Jul 26;6(14):4216-4223. doi: 10.1182/bloodadvances.2022007454. Blood Adv. 2022. PMID: 35580321 Free PMC article.
Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma.
Shinohara S, Takebayashi S, Hamaguchi K, Michida T, Tobe Y, Ikenaga T, Yasumoto M, Hamamoto A, Imagumbai T, Mitsuyoshi T, Ashida R, Iwai T, Okabayashi S. Shinohara S, et al. Among authors: mitsuyoshi t. Clin Med Insights Oncol. 2021 Oct 4;15:11795549211048417. doi: 10.1177/11795549211048417. eCollection 2021. Clin Med Insights Oncol. 2021. PMID: 34629923 Free PMC article.
Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
Seo S, Usui Y, Matsuo K, Atsuta Y, Igarashi A, Fukuda T, Ozawa Y, Katayama Y, Yoshida S, Uchida N, Kondo T, Kako S, Tsukada N, Kato S, Onizuka M, Ichinohe T, Kimura F, Kanda Y, Miyamura K, Kanda J; JSHCT Donor Source Working Group. Seo S, et al. Bone Marrow Transplant. 2021 Oct;56(10):2410-2422. doi: 10.1038/s41409-021-01289-8. Epub 2021 May 14. Bone Marrow Transplant. 2021. PMID: 33990702
Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.
Shintani T, Kishi N, Matsuo Y, Ogura M, Mitsuyoshi T, Araki N, Fujii K, Okumura S, Nakamatsu K, Kishi T, Atsuta T, Sakamoto T, Narabayashi M, Ishida Y, Sakamoto M, Fujishiro S, Katagiri T, Kim YH, Mizowaki T. Shintani T, et al. Among authors: mitsuyoshi t. Clin Lung Cancer. 2021 Sep;22(5):401-410. doi: 10.1016/j.cllc.2021.01.017. Epub 2021 Feb 4. Clin Lung Cancer. 2021. PMID: 33678582
44 results